Viral Clearance Market

Figure 2.1 Executive Summary: Overall Market Landscape

Figure 2.2 Executive Summary: Patent Analysis

Figure 2.3 Executive Summary: Recent Developments

Figure 2.4 Executive Summary: Market Sizing and Opportunity Analysis

Figure 3.1 Sources of Viral Contamination

Figure 3.2 Process of Viral Clearance and Testing

Figure 4.1 Viral Clearance Testing Service Providers: Distribution by Year of Establishment

Figure 4.2 Viral Clearance Testing Service Providers: Distribution by Company Size

Figure 4.3 Viral Clearance Testing Service Providers: Distribution by Location of Headquarters

Figure 4.4 Viral Clearance Testing Service Providers: Distribution by Company Size and Location of Headquarters (Region)

Figure 4.5 Viral Clearance Testing Service Providers: Distribution by Location of Viral Clearance and Testing Facilities

Figure 4.6 Viral Clearance Testing Service Providers: Distribution by Type of Virus Detected (by Envelope)

Figure 4.7 Viral Clearance Testing Service Providers: Distribution by Type of Virus Detected (by Class)

Figure 4.8 Viral Clearance Testing Service Providers: Distribution by Key Offerings

Figure 4.9 Viral Clearance Testing Service Providers: Distribution by Type of Biologic(s) Analyzed

Figure 4.10 Viral Clearance Testing Service Providers: Distribution by Method(s) of Viral Clearance (Inactivation)

Figure 4.11 Viral Clearance Testing Service Providers: Distribution by Method(s) of Viral Clearance (Removal)

Figure 4.12 Viral Clearance Testing Service Providers: Distribution by Type of Viral Testing Service(s) Offered

Figure 5.1 Competitiveness Analysis of Viral Clearance Testing Service Providers in North America

Figure 5.2 Competitiveness Analysis of Viral Clearance Testing Service Providers in Europe

Figure 5.3 Competitiveness Analysis of Viral Clearance Testing Service Providers in Asia-Pacific and Rest of the World

Figure 6.1 Charles River Laboratories: Annual Revenues, 2017-9M 2022 (USD Billion)

Figure 6.2 Nelson Labs: Annual Revenues, 2019-9M 2022 (USD Million)

Figure 6.3 Danaher (parent company of Pall): Annual Revenues, 2017-9M 2022 (USD Billion)

Figure 7.1 Eurofins Scientific: Annual Revenues, 2017-9M 2022 (EUR Billion)

Figure 7.2 Syngene International: Annual Revenues, FY 2018-FY H1 2023 (INR Billion)

Figure 8.1 Patent Analysis: Distribution by Type of Patent

Figure 8.2 Patent Analysis: Cumulative Distribution by Patent Publication Year, 2017-2022

Figure 8.3 Patent Analysis: Cumulative Distribution of Patent Applications, Pre- 2017-2022

Figure 8.4 Patent Analysis: Distribution by Type of Patent and Patent Publication Year, 2017-2022

Figure 8.5 Patent Analysis: Cumulative Year-wise Distribution by Type of Organization, 2017-2022

Figure 8.6 Patent Analysis: Emerging Focus Areas

Figure 8.7 Patent Analysis: Distribution by Geography

Figure 8.8 Patent Analysis: Distribution by CPC Symbols

Figure 8.9 Patent Analysis: Leading Players

Figure 8.10 Patent Analysis (Leading Players): Benchmarking by Patent Characteristics (CPC Symbols)

Figure 8.11 Patent Analysis: Distribution of Patents by Age

Figure 8.12 Viral Clearance Testing: Patent Valuation

Figure 9.1 Partnerships and Collaborations: Cumulative Year-wise Trend, 2015-2022

Figure 9.2 Partnerships and Collaborations: Distribution by Type of Partnership

Figure 9.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership, 2015-2022

Figure 9.4 Partnerships and Collaborations: Distribution by Purpose of Partnership

Figure 9.5 Partnerships and Collaborations: Distribution by Type of Organization, 2015-2022

Figure 9.6 Partnerships and Collaborations: Distribution by Location of Facility (Country)

Figure 9.7 Partnerships and Collaborations: Distribution by Location of Facility (Region)

Figure 9.8 Most Active Players: Distribution by Number of Partnerships

Figure 9.9 Partnerships and Collaborations: Distribution by Geography

Figure 9.10 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements

Figure 9.11 Recent Expansions: Cumulative Year-wise Trend, 2017-2022

Figure 9.12 Recent Expansions: Distribution by Type of Expansion

Figure 9.13 Recent Expansions: Distribution by Focus of Expansion

Figure 9.14 Recent Expansions: Distribution by Type of Service(s) Offered

Figure 9.15 Recent Expansions: Distribution by Type of Biologic(s) Involved

Figure 9.16 Recent Expansions: Distribution by Type of Expansion and Service(s) Offered

Figure 9.17 Recent Expansions: Distribution by Type of Expansion and Biologic(s) Involved

Figure 9.18 Most Active Players: Distribution by Number of Expansions

Figure 9.19 Recent Expansions: Distribution by Geography

Figure 9.20 Recent Expansions: Distribution by Location of Expansion Project

Figure 10.1 Global Viral Clearance Market, 2023-2035 (USD Million)

Figure 10.2 Viral Clearance Market: Distribution by Scale of Operation, 2023 and 2035 (USD Million)

Figure 10.3 Viral Clearance Market for Discovery Phase, 2023-2035 (USD Million)

Figure 10.4 Viral Clearance Market for Preclinical Phase, 2023-2035 (USD Million)

Figure 10.5 Viral Clearance Market for Clinical Phase, 2023-2035 (USD Million)

Figure 10.6 Viral Clearance Market: Distribution by Method of Viral Clearance and Testing, 2023 and 2035 (USD Million)

Figure 10.7 Viral Clearance Market for Viral Detection, 2023-2035 (USD Million)

Figure 10.8 Viral Clearance Market for Viral Inactivation, 2023-2035 (USD Million)

Figure 10.9 Viral Clearance Market for Viral Removal, 2023-2035 (USD Million)

Figure 10.10 Viral Clearance Market: Distribution by End-User, 2023 and 2035 (USD Million)

Figure 10.11 Viral Clearance Market for Biotechnology and Pharmaceutical Companies, 2023-2035 (USD Million)

Figure 10.12 Viral Clearance Market for Academic / Research Institutes, 2023-2035 (USD Million)

Figure 10.13 Viral Clearance Market: Distribution by Key Geographical Regions, 2023 and 2035 (USD Million)

Figure 10.14 Viral Clearance Market in North America, 2023-2035 (USD Million)

Figure 10.15 Viral Clearance Market in Europe, 2023-2035 (USD Million)

Figure 10.16 Viral Clearance Market in Asia-Pacific, 2023-2035 (USD Million)

Figure 10.17 Viral Clearance Market in Rest of the World, 2023-2035 (USD Million)

Figure 11.1 Concluding Remarks: Overall Market Landscape

Figure 11.2 Concluding Remarks: Patent Analysis

Figure 11.3 Concluding Remarks: Recent Developments

Figure 11.4 Concluding Remarks: Market Sizing and Opportunity Analysis

Table 4.1 Viral Clearance Testing Service Providers: Information on Company, Year of Establishment, Company Size, Location of Headquarters and Location of Viral Clearance Testing Service Facilities

Table 4.2 Viral Clearance Testing Service Providers: Information on Type of Virus Detected (by Envelope) and Type of Virus Detected (by Class)

Table 4.3 Viral Clearance Testing Service Providers: Information on Key Offerings and Type of Biologic(s) Analyzed

Table 4.4 Viral Clearance Testing Service Providers: Information on Method(s) of Viral Clearance (Inactivation), Method(s) of Viral Clearance (Removal) and Type of Viral Testing Service(s) Offered

Table 6.1 Viral Clearance Testing Service Providers in North America: List of Companies Profiled

Table 6.2 Charles River Laboratories: Company Snapshot

Table 6.3 Charles River Laboratories: Overview of Viral Clearance and Testing Services

Table 6.4 Charles River Laboratories: Recent Developments and Future Outlook

Table 6.5 Microbac Laboratories: Company Snapshot

Table 6.6 Microbac Laboratories: Overview of Viral Clearance and Testing Services

Table 6.7 Nelson Labs: Company Snapshot

Table 6.8 Nelson Labs: Overview of Viral Clearance and Testing Services

Table 6.9 Nelson Labs: Recent Developments and Future Outlook

Table 6.10 Pall Corporation: Company Snapshot

Table 6.11 Pall Corporation: Overview of Viral Clearance and Testing Services

Table 7.1 Viral Clearance Testing Service Providers in Europe and Asia-Pacific: List of Companies Profiled

Table 7.2 Eurofins Scientific: Company Snapshot

Table 7.3 Eurofins Scientific: Overview of Viral Clearance and Testing Services

Table 7.4 Eurofins Scientific: Recent Developments and Future Outlook

Table 7.5 Syngene International: Company Snapshot

Table 7.6 Syngene International: Overview of Viral Clearance and Testing Services

Table 7.7 Syngene International: Recent Developments and Future Outlook

Table 7.8 Texcell: Company Snapshot

Table 7.9 Texcell: Overview of Viral Clearance and Testing Services

Table 7.10 Texcell: Recent Developments and Future Outlook

Table 8.1 Patent Analysis: CPC Sections

Table 8.2 Patent Analysis: CPC Codes

Table 8.3 Patent Analysis: CPC Symbol

Table 8.4 Patent Analysis: Summary of Benchmarking Analysis

Table 8.5 Patent Analysis: Categorization based on Weighted Valuation Scores

Table 8.6 Patent Portfolio: List of Leading Patents (by Highest Relative Valuation)

Table 8.7 Patent Portfolio: List of Leading Patents (by Number of Citations)

Table 9.1 Viral Clearance Testing Service Providers: List of Partnerships and Collaborations, 2015-2022

Table 9.2 Partnerships and Collaborations: Information on Purpose of Partnership, Type of Organization, Location of Facility (Country) and Location of Facility (Region), 2015-2022

Table 9.3 Viral Clearance Testing Service Providers: List of Recent Expansions, 2017-2022

Table 9.4 Recent Expansions: Information on Type of Service(s) Offered and Type of Biologic(s) Involved, 2017-2022

Table 12.1 hylabs: Company Snapshot

Table 12.2 WuXi Biologics: Company Snapshot

Table 13.1 Viral Clearance Testing Service Providers: Distribution by Year of Establishment

Table 13.2 Viral Clearance Testing Service Providers: Distribution by Company Size

Table 13.3 Viral Clearance Testing Service Providers: Distribution by Location of Headquarters

Table 13.4 Viral Clearance Testing Service Providers: Distribution by Company Size and Location of Headquarters (Region)

Table 13.5 Viral Clearance Testing Service Providers: Distribution by Type of Virus Detected (by Envelope)

Table 13.6 Viral Clearance Testing Service Providers: Distribution by Type of Virus Detected (by Class)

Table 13.7 Viral Clearance Testing Service Providers: Distribution by Key Offerings

Table 13.8 Viral Clearance Testing Service Providers: Distribution by Type of Biologic(s) Analyzed

Table 13.9 Viral Clearance Testing Service Providers: Distribution by Method(s) of Viral Clearance (Inactivation)

Table 13.10 Viral Clearance Testing Service Providers: Distribution by Method(s) of Viral Clearance (Removal)

Table 13.11 Viral Clearance Testing Service Providers: Distribution by Type of Viral Testing Service(s) Offered

Table 13.12 Charles River Laboratories: Annual Revenues, 2017-9M 2022 (USD Billion)

Table 13.13 Nelson Labs: Annual Revenues, 2019-9M 2022 (USD Million)

Table 13.14 Danaher (parent company of Pall): Annual Revenues, 2017-9M 2022 (USD Billion)

Table 13.15 Eurofins Scientific: Annual Revenues, 2017-9M 2022 (EUR Billion)

Table 13.16 Syngene International: Annual Revenues, FY 2018-FY H1 2023 (INR Billion)

Table 13.17 Patent Analysis: Distribution by Type of Patent

Table 13.18 Patent Analysis: Cumulative Distribution by Patent Publication Year, 2017-2022

Table 13.19 Patent Analysis: Cumulative Distribution of Patent Applications, Pre- 2017-2022

Table 13.20 Patent Analysis: Distribution by Type of Patent and Patent Publication Year, 2017-2022

Table 13.21 Patent Analysis: Cumulative Year-wise Distribution by Type of Organization, 2017-2022

Table 13.22 Patent Analysis: Emerging Focus Areas

Table 13.23 Patent Analysis: Distribution by Geography

Table 13.24 Patent Analysis: Distribution by CPC Symbols

Table 13.25 Patent Analysis: Leading Players

Table 13.26 Patent Analysis (Leading Players): Benchmarking by Patent Characteristics (CPC Symbols)

Table 13.27 Patent Analysis: Distribution of Patents by Age

Table 13.28 Viral Clearance Testing: Patent Valuation

Table 13.29 Partnerships and Collaborations: Cumulative Year-wise Trend, 2015-2022

Table 13.30 Partnerships and Collaborations: Distribution by Type of Partnership

Table 13.31 Partnerships and Collaborations: Distribution by Year and Type of Partnership, 2015-2022

Table 13.32 Partnerships and Collaborations: Distribution by Purpose of Partnership

Table 13.33 Partnerships and Collaborations: Distribution by Type of Organization, 2015-2022

Table 13.34 Partnerships and Collaborations: Distribution by Location of Facility (Region)

Table 13.35 Most Active Players: Distribution by Number of Partnerships

Table 13.36 Partnerships and Collaborations: Distribution by Geography

Table 13.37 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements

Table 13.38 Recent Expansions: Cumulative Year-wise Trend, 2017-2022

Table 13.39 Recent Expansions: Distribution by Type of Expansion

Table 13.40 Recent Expansions: Distribution by Focus of Expansion

Table 13.41 Recent Expansions: Distribution by Type of Service(s) Offered

Table 13.42 Recent Expansions: Distribution by Type of Biologic(s) Involved

Table 13.43 Recent Expansions: Distribution by Type of Expansion and Service(s) Offered

Table 13.44 Recent Expansions: Distribution by Type of Expansion and Biologic(s) Involved

Table 13.45 Most Active Players: Distribution by Number of Expansions

Table 13.46 Recent Expansions: Distribution by Geography

Table 13.47 Recent Expansions: Distribution by Location of Expansion Project

Table 13.48 Global Viral Clearance Market: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)

Table 13.49 Viral Clearance Market: Distribution by Scale of Operation, 2023 and 2035 (USD Million)

Table 13.50 Viral Clearance Market for Discovery Phase: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)

Table 13.51 Viral Clearance Market for Preclinical Phase: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)

Table 13.52 Viral Clearance Market for Clinical Phase: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)

Table 13.53 Viral Clearance Market: Distribution by Method of Viral Clearance and Testing, 2023 and 2035 (USD Million)

Table 13.54 Viral Clearance Market for Viral Detection: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)

Table 13.55 Viral Clearance Market for Viral Inactivation: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)

Table 13.56 Viral Clearance Market for Viral Removal: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)

Table 13.57 Viral Clearance Market: Distribution by End-User, 2023 and 2035 (USD Million)

Table 13.58 Viral Clearance Market for Biotechnology and Pharmaceutical Companies: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)

Table 13.59 Viral Clearance Market for Academic / Research Institutes: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)

Table 13.60 Viral Clearance Market: Distribution by Key Geographical Regions, 2023 and 2035 (USD Million)

Table 13.61 Viral Clearance Market in North America: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)

Table 13.62 Viral Clearance Market in Europe: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)

Table 13.63 Viral Clearance Market in Asia-Pacific: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)

Table 13.64 Viral Clearance Market in Rest of the World: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Million)

Please reach out to our team for more details.